Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

Exclusion Criteria

• •1. For those subjects not treated for their ADHD at the time of enrollment, a history of non-response or intolerance to methylphenidate at adequate doses as determined by the clinician.
• •2. A history of intolerance to omega-3 fatty acids as determined by the clinician.
• •3. Pregnant or nursing females.
• •4. Serious, unstable medical illness including hepatic, renal, gastroenterological, respiratory, cardiovascular, endocrinologic (thyroid), neurologic (seizure), immunologic, or hematologic disease.
• •5. Glaucoma.
• •6. Clinically unstable psychiatric conditions including suicidality, homicidality, bipolar disorder, psychosis, or lifetime history of a clinically serious condition potentially exacerbated by a stimulant such as mania, or psychosis.
• •7. Tics or a family history or diagnosis of Tourette's syndrome.
• •8. Current (within 3 months) DSM-IV criteria for abuse or dependence with any psychoactive substance other than nicotine.
• •9. Allergies to fish or shellfish; multiple adverse drug reactions.
• •10. Any other concomitant medication with primarily central nervous system activity other than specified in Concomitant Medication portion of the protocol.
• •11. Current use of Monoamine Oxidase (MAO) Inhibitor or use within the past two weeks.
• •12. Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild.